Abstract Background and Aims Vaccines are the first line of defense against coronavirus
disease 2019 (Covid‐19). However, the antiviral drugs provide a new tool to fight the Covid …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide,
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …

SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …

Since the beginning of the COVID-19 pandemic, large in silico screening studies and
numerous in vitro studies have assessed the antiviral activity of various drugs on SARS-CoV …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently
affecting more than 200 countries and territories worldwide. It has been declared as …

Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19,
which has spread worldwide. No specific therapies/vaccines are yet available for the …

The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

Context• Drug repurposing is a relevant approach during the COVID-19 pandemic, because
development of new drugs is time-consuming and costly, and the safety of new drugs is …